Overview
Promoted products
Pharmaceutical brands that solve unmet needs in the markets for health care providers, physicians and patients – currently 2 main franchises: rheumathoid arthritis, medical termination of pregnancy.
Methotrexate
Mifepristone
Methotrexate
Non promoted products
Range of classical generics at attractive price/volume combinations spanning many TAs and technology types
Hard-to-Make generics threatened by supply shortages for payors and wholesalers
Desmopressin
Tranezamic acid
Branded generics that fulfill government-designated public health needs such as in HIV in Russia; these products bridge transition during originator patent expiry
Antiretrovirals
Anticancer
Pharmaceutical Services
Pharmaceutical development and production services with unique capabilities (e.g., polymers)
Dev‘t and mfg
capabilities
Polymer
technology
Drug rediscovery in new and higher value indications for institutions and consortia
Drug repurposing
Geographies
Commercially, Sever companies operate mainly in US and Canada, Western Europe, Russia, Japan
Manufacturing
Sever has 4 development and manufacturing sites across the world and cover a range of technologies from oral solids to poymers
Farmaprim
Moldova
Izvarino and
Nanopharm
Russia
Malmö
Sweden